Market Analysis and Insights: Global Glutamine (Gln) Market

L-Glutamine, short as Gln, is the most abundant amino acid in the body. It is responsible for transporting nitrogen into your muscles. Glutamine also plays a large role in metabolism, the functioning of your immune system, protein synthesis and energy restoration.

In this report we only counting the glutamine products which circulate on the market, not including the glutamine products which are used for manufacture other products directly by the glutamine manufacturers. Namely the glutamine products which not enter into the market are excluded in this report.

Due to the COVID-19 pandemic, the global Glutamine (Gln) market size is estimated to be worth US$ 144.4 million in 2022 and is forecast to a readjusted size of US$ 181.9 million by 2029 with a CAGR of 3.3% during the forecast period 2023-2029. Fully considering the economic change by this health crisis, Pharmaceutical Grade accounting for % of the Glutamine (Gln) global market in 2022, is projected to value US$ million by 2029, growing at a revised % CAGR from 2023 to 2029. While Nutraceutical Use segment is altered to an % CAGR throughout this forecast period.

The global Glutamine (Gln) industry has a rather high concentration. The major manufacturers are concentrated in USA, Japan, China and Korea, such as Ajinomoto, Kyowa Hakko Kirin, Daesang, Meihua and Fufeng. At present, Ajinomoto is the world leader, holding 26% production market share.

USA is the largest region consumption market, accounting for about 34% of global consumption of Glutamine (Gln).

Glutamine (Gln) can be mainly divided into Pharmaceutical Grade, Nutraceutical Grade and Other which Nutraceutical Grade captures about 64% of Glutamine (Gln) market. According to our research and analysis, manufacturers from USA are the major leaders in the international market of Glutamine (Gln).

Global Glutamine (Gln) Scope and Market Size

The global Glutamine (Gln) market is segmented by company, region (country), type and application. Players, stakeholders, and other participants in the global Glutamine (Gln) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), type and application for the period 2018-2029.


Segment by Type


Pharmaceutical Grade

Nutraceutical Grade

Others


Segment by Application


Nutraceutical Use

Pharmaceutical Use

Others

By Region

United States

Europe

China

Japan

Southeast Asia

India

Other Regions


By Company


Ajinomoto

Kyowa Hakko Kirin

Daesang

Meihua

Fufeng